Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Jan 30;14(1):e21738.
doi: 10.7759/cureus.21738. eCollection 2022 Jan.

Peritumoral Immunoglobulin M Lambda Light Chain Amyloidosis in a Patient With Advanced Follicular Lymphoma

Affiliations
Case Reports

Peritumoral Immunoglobulin M Lambda Light Chain Amyloidosis in a Patient With Advanced Follicular Lymphoma

Kalpesh Shah et al. Cureus. .

Abstract

Peritumoral light chain (AL) amyloidosis secondary to lymphoid malignancies is a rare but well-described entity. Peritumoral deposition of amyloid without systemic amyloidosis has been described in mucosa-associated lymphoid tissue (MALT) lymphomas; however, there are no reported cases of follicular lymphoma with localized peritumoral AL amyloidosis without systemic involvement of amyloidosis. We present a rare case of a patient with advanced follicular lymphoma with peritumoral lymph node IgM lambda light chain amyloidosis without an underlying monoclonal gammopathy or plasma cell dyscrasia.

Keywords: amyloidosis; follicular; light chain; lymphoma; peritumoral.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. A (left) reveals H&E staining for centroblasts and centrocytes, and B (right) reveals H&E staining revealing amyloid
Figure 2
Figure 2. A (left) reveals positive staining for CD20, and B (right) reveals positive staining for BCL2
Figure 3
Figure 3. A (left) reveals positive staining for Congo red stain, and B (right) reveals positive staining for BCL6

References

    1. Systemic AL amyloidosis due to non-Hodgkin's lymphoma: an unusual clinicopathologic association. Cohen AD, Zhou P, Xiao Q, et al. Br J Haematol. 2004;124:309–314. - PubMed
    1. Amyloid nomenclature 2018: recommendations by the International Society of Amyloidosis (ISA) nomenclature committee. Benson MD, Buxbaum JN, Eisenberg DS, et al. Amyloid. 2018;25:215–219. - PubMed
    1. Exploring the amyloid proteome in immunoglobulin-derived lymph node amyloidosis using laser microdissection/tandem mass spectrometry. D'Souza A, Theis J, Quint P, et al. Am J Hematol. 2013;88:577–580. - PubMed
    1. Two distinct syndromes of lymphoma-associated AL amyloidosis: a case series and review of the literature. Telio D, Bailey D, Chen C, Crump M, Reece D, Kukreti V. Am J Hematol. 2010;85:805–808. - PubMed
    1. Primary localized amyloidosis of the urinary bladder: a case series of 31 patients. Tirzaman O, Wahner-Roedler DL, Malek RS, Sebo TJ, Li CY, Kyle RA. Mayo Clin Proc. 2000;75:1264–1268. - PubMed

Publication types

LinkOut - more resources